Inflammatory markers in women with a recent history of gestational diabetes mellitus

被引:58
作者
Di Benedetto, A
Russo, GT
Corrado, F
Di Cesare, E
Alessi, E
Nicocia, G
D'Anna, R
Cucinotta, D
机构
[1] Univ Messina, Dept Internal Med, Messina, Italy
[2] Univ Messina, Dept Gynecol Sci, Messina, Italy
[3] Univ Messina, Dept Expt Pathol & Microbiol, Messina, Italy
关键词
CRP; MCP-1/CCL2; fibrinogen; gestational diabetes; cardiovascular disease;
D O I
10.1007/BF03345527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gestational diabetes mellitus (GDM) is a risk factor for both Type 2 diabetes (DM2) and insulin-resistance syndrome (IRS). C-reactive protein (CRP), fibrinogen and leukocyte count are increased in the IRS and predict DM2 and cardiovascular disease (CVD). The chemochine monocyte chemoattractant protein-1 (MCP-1/CCL2) is also elevated in DM2 and CVD. Recent evidence suggests a relation between chronic inflammation and GDM, but post-delivery information on inflammatory markers in these high-risk women is lacking. Serum levels of CRP, fibrinogen, MCP-1/CCL2, and leukocyte blood count have been assessed in 26 women with and 26 women without a recent history of GDM, matched for age, body mass index (BMI), post-partum duration and parity. DM2 was excluded in all the participants by an oral glucose tolerance test (OGTT). Women with previous GDM showed significantly higher CRP (p=0.007) and fibrinogen (p=0.02) serum concentrations, whereas MCP-1/CCL2 serum levels and leukocyte blood count were comparable in the two groups. Overall, CRP levels significantly correlated with BMI (r=0.40, p=0.03), waist-to-hip ratio (WHR) (r=0.44, p=0.001), fasting insulin (r=0.27, p=0.04), insulin-resistance assessed by means of the homeostatic model (HOMA) (r=0.28, p=0.04), and fibrinogen concentration (r=0.49, p=0.0001). At linear regression analysis, only WHR and fibrinogen were independently associated with CRP levels. In conclusion, the increase of inflammatory markers may be one of the first detectable disorders in healthy women at high risk of DM2 and IRS, like those with a GDM history.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 29 条
[11]   Suppression of nuclear factor-κB and stimulation of inhibitor κB by troglitazone:: Evidence for an antiinflammatory effect and a potential antiatherosclerotic effect in the obese [J].
Ghanim, H ;
Garg, R ;
Aljada, A ;
Mohanty, P ;
Kumbkarni, Y ;
Assian, E ;
Hamouda, W ;
Dandona, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1306-1312
[12]   ABDOMINAL OBESITY IS ASSOCIATED WITH AN IMPAIRED FIBRINOLYTIC-ACTIVITY AND ELEVATED PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
LANDIN, K ;
STIGENDAL, L ;
ERIKSSON, E ;
KROTKIEWSKI, M ;
RISBERG, B ;
TENGBORN, L ;
SMITH, U .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (10) :1044-1048
[13]   HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN [J].
MATTHEWS, DR ;
HOSKER, JP ;
RUDENSKI, AS ;
NAYLOR, BA ;
TREACHER, DF ;
TURNER, RC .
DIABETOLOGIA, 1985, 28 (07) :412-419
[14]   Lipid levels in former gestational diabetic mothers [J].
MeyersSeifer, CH ;
Vohr, BR .
DIABETES CARE, 1996, 19 (12) :1351-1356
[15]   Significance of chemokines and activated platelets in patients with diabetes [J].
Nomura, S ;
Shouzu, A ;
Omoto, S ;
Nishikawa, M ;
Fukuhara, S .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (03) :437-443
[16]  
Pasceri V, 2001, CIRCULATION, V103, P2531
[17]   Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association [J].
Pearson, TA ;
Mensah, GA ;
Alexander, RW ;
Anderson, JL ;
Cannon, RO ;
Criqui, M ;
Fadl, YY ;
Fortmann, SP ;
Hong, Y ;
Myers, GL ;
Rifai, N ;
Smith, SC ;
Taubert, K ;
Tracy, RP ;
Vinicor, F .
CIRCULATION, 2003, 107 (03) :499-511
[18]   Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes [J].
Pickup, JC .
DIABETES CARE, 2004, 27 (03) :813-823
[19]   Is Type II diabetes mellitus a disease of the innate immune system? [J].
Pickup, JC ;
Crook, MA .
DIABETOLOGIA, 1998, 41 (10) :1241-1248
[20]   Fasting plasma leptin, tumor necrosis factor-α receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women -: Impact on cardiovascular mortality [J].
Piemonti, L ;
Calori, G ;
Mercalli, A ;
Lattuada, G ;
Monti, P ;
Garancini, MP ;
Costantino, F ;
Ruotolo, G ;
Luzi, L ;
Perseghin, G .
DIABETES CARE, 2003, 26 (10) :2883-2889